structure of 4-Amino-3-bromo-5-iodobenzonitrile

4-Amino-3-bromo-5-iodobenzonitrile

CAS No.: 1000578-00-6
M. Wt: 322.92900
M. Fa: C7H4BrIN2
InChI Key: ZXCXPHSSIDEPDP-UHFFFAOYSA-N
Appearance: Solid

Names and Identifiers of 4-Amino-3-bromo-5-iodobenzonitrile

CAS Number

1000578-00-6

MDL Number

MFCD09800820

IUPAC Name

4-amino-3-bromo-5-iodobenzonitrile

InChI

InChI=1S/C7H4BrIN2/c8-5-1-4(3-10)2-6(9)7(5)11/h1-2H,11H2

InChIKey

ZXCXPHSSIDEPDP-UHFFFAOYSA-N

Canonical SMILES

N#CC1=CC(Br)=C(N)C(I)=C1

UNSPSC Code

12352100

Physical and chemical properties of 4-Amino-3-bromo-5-iodobenzonitrile

Exact Mass

321.86000

LogP

3.08878

Melting Point

157 to 160°C

Molecular Formula

C7H4BrIN2

Molecular Weight

322.92900

PSA

49.81000

Safety Information of 4-Amino-3-bromo-5-iodobenzonitrile

Pictograms

Signal Word

Warning

Safety Data Sheet

Supports customized editing of SDS information and downloading in PDF documents.

Applications of 4-Amino-3-bromo-5-iodobenzonitrile

4-Amino-3-bromo-5-iodobenzonitrile has several significant applications:

  • Organic Synthesis: It serves as a versatile building block for synthesizing more complex organic molecules.
  • Medicinal Chemistry: Its role as an intermediate in drug development is critical, particularly in designing compounds with specific biological activities.
  • Material Science: The compound is also utilized in the synthesis of heterocycles and liquid crystals, which are important for electronic applications.

Interaction Studies of 4-Amino-3-bromo-5-iodobenzonitrile

Research on 4-Amino-3-bromo-5-iodobenzonitrile has indicated its potential interactions with various biomolecules. Studies focusing on its inhibitory effects on cytochrome P450 enzymes suggest that it may alter the metabolism of co-administered drugs. Such interactions are essential for understanding its pharmacokinetics and potential side effects when used therapeutically.

Biological Activity of 4-Amino-3-bromo-5-iodobenzonitrile

4-Amino-3-bromo-5-iodobenzonitrile exhibits notable biological activities that make it relevant in pharmaceutical research. It has been identified as a potential inhibitor of certain cytochrome P450 enzymes, which are crucial for drug metabolism. Specifically, it has shown inhibitory effects on CYP1A2 and CYP2C9, indicating its potential role in drug-drug interactions. Furthermore, its structural characteristics may enable it to interact with various biological targets, making it a candidate for further investigation in drug development.